REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,760 | -13.5% | 2,616 | +17.4% | 0.00% | -33.3% |
| Q2 2023 | $51,757 | +15.9% | 2,229 | -11.8% | 0.00% | +50.0% |
| Q1 2023 | $44,644 | -33.1% | 2,528 | +3.1% | 0.00% | -33.3% |
| Q4 2022 | $66,694 | +57.5% | 2,452 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $42,346 | +39.4% | 2,452 | +41.1% | 0.00% | +100.0% |
| Q2 2022 | $30,380 | +2.9% | 1,738 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $29,511 | -84.6% | 1,738 | -75.5% | 0.00% | -66.7% |
| Q4 2021 | $191,922 | -8.6% | 7,082 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $209,910 | -22.9% | 7,082 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $272,090 | +32.6% | 7,082 | +5.3% | 0.00% | +33.3% |
| Q1 2021 | $205,180 | -20.0% | 6,725 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $256,559 | +65.7% | 6,725 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $154,810 | -2.0% | 6,725 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $158,021 | – | 6,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |